0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Mycobacterium Tuberculosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-14Q7881
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Mycobacterium Tuberculosis Market Insights and Forecast to 2028
BUY CHAPTERS

Mycobacterium Tuberculosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-14Q7881
Report
November 2024
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mycobacterium Tuberculosis - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Mycobacterium Tuberculosis - Market

Mycobacterium Tuberculosis - Market

The global market for Mycobacterium Tuberculosis was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mycobacterium Tuberculosis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Mycobacterium Tuberculosis by region & country, by Type, and by Application.
The Mycobacterium Tuberculosis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycobacterium Tuberculosis.
Market Segmentation

Scope of Mycobacterium Tuberculosis - Market Report

Report Metric Details
Report Name Mycobacterium Tuberculosis - Market
CAGR 5%
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson, Pfizer, Novartis, Abbott, AstraZeneca, Bayer, Merck, Sanofi, Thermo Fisher Scientific, Danaher, Roche
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Mycobacterium Tuberculosis manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Mycobacterium Tuberculosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Mycobacterium Tuberculosis in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Mycobacterium Tuberculosis - Market report?

Ans: The main players in the Mycobacterium Tuberculosis - Market are Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson, Pfizer, Novartis, Abbott, AstraZeneca, Bayer, Merck, Sanofi, Thermo Fisher Scientific, Danaher, Roche

What are the Application segmentation covered in the Mycobacterium Tuberculosis - Market report?

Ans: The Applications covered in the Mycobacterium Tuberculosis - Market report are Hospital, Specialist Clinic, Diagnostic Laboratory

What are the Type segmentation covered in the Mycobacterium Tuberculosis - Market report?

Ans: The Types covered in the Mycobacterium Tuberculosis - Market report are Real-time Inspection, Nucleic Acid Amplification Test, Skin Test for Tuberculosis, Other

Recommended Reports

Anti-Infective Markets

Respiratory Diseases

Drug Market Trends

1 Market Overview
1.1 Mycobacterium Tuberculosis Product Introduction
1.2 Global Mycobacterium Tuberculosis Market Size Forecast
1.3 Mycobacterium Tuberculosis Market Trends & Drivers
1.3.1 Mycobacterium Tuberculosis Industry Trends
1.3.2 Mycobacterium Tuberculosis Market Drivers & Opportunity
1.3.3 Mycobacterium Tuberculosis Market Challenges
1.3.4 Mycobacterium Tuberculosis Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Mycobacterium Tuberculosis Players Revenue Ranking (2023)
2.2 Global Mycobacterium Tuberculosis Revenue by Company (2019-2024)
2.3 Key Companies Mycobacterium Tuberculosis Manufacturing Base Distribution and Headquarters
2.4 Key Companies Mycobacterium Tuberculosis Product Offered
2.5 Key Companies Time to Begin Mass Production of Mycobacterium Tuberculosis
2.6 Mycobacterium Tuberculosis Market Competitive Analysis
2.6.1 Mycobacterium Tuberculosis Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Mycobacterium Tuberculosis Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycobacterium Tuberculosis as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Real-time Inspection
3.1.2 Nucleic Acid Amplification Test
3.1.3 Skin Test for Tuberculosis
3.1.4 Other
3.2 Global Mycobacterium Tuberculosis Sales Value by Type
3.2.1 Global Mycobacterium Tuberculosis Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Mycobacterium Tuberculosis Sales Value, by Type (2019-2030)
3.2.3 Global Mycobacterium Tuberculosis Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Specialist Clinic
4.1.3 Diagnostic Laboratory
4.2 Global Mycobacterium Tuberculosis Sales Value by Application
4.2.1 Global Mycobacterium Tuberculosis Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Mycobacterium Tuberculosis Sales Value, by Application (2019-2030)
4.2.3 Global Mycobacterium Tuberculosis Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Mycobacterium Tuberculosis Sales Value by Region
5.1.1 Global Mycobacterium Tuberculosis Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Mycobacterium Tuberculosis Sales Value by Region (2019-2024)
5.1.3 Global Mycobacterium Tuberculosis Sales Value by Region (2025-2030)
5.1.4 Global Mycobacterium Tuberculosis Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Mycobacterium Tuberculosis Sales Value, 2019-2030
5.2.2 North America Mycobacterium Tuberculosis Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Mycobacterium Tuberculosis Sales Value, 2019-2030
5.3.2 Europe Mycobacterium Tuberculosis Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Mycobacterium Tuberculosis Sales Value, 2019-2030
5.4.2 Asia Pacific Mycobacterium Tuberculosis Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Mycobacterium Tuberculosis Sales Value, 2019-2030
5.5.2 South America Mycobacterium Tuberculosis Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Mycobacterium Tuberculosis Sales Value, 2019-2030
5.6.2 Middle East & Africa Mycobacterium Tuberculosis Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Mycobacterium Tuberculosis Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Mycobacterium Tuberculosis Sales Value
6.3 United States
6.3.1 United States Mycobacterium Tuberculosis Sales Value, 2019-2030
6.3.2 United States Mycobacterium Tuberculosis Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Mycobacterium Tuberculosis Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Mycobacterium Tuberculosis Sales Value, 2019-2030
6.4.2 Europe Mycobacterium Tuberculosis Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Mycobacterium Tuberculosis Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Mycobacterium Tuberculosis Sales Value, 2019-2030
6.5.2 China Mycobacterium Tuberculosis Sales Value by Type (%), 2023 VS 2030
6.5.3 China Mycobacterium Tuberculosis Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Mycobacterium Tuberculosis Sales Value, 2019-2030
6.6.2 Japan Mycobacterium Tuberculosis Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Mycobacterium Tuberculosis Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Mycobacterium Tuberculosis Sales Value, 2019-2030
6.7.2 South Korea Mycobacterium Tuberculosis Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Mycobacterium Tuberculosis Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Mycobacterium Tuberculosis Sales Value, 2019-2030
6.8.2 Southeast Asia Mycobacterium Tuberculosis Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Mycobacterium Tuberculosis Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Mycobacterium Tuberculosis Sales Value, 2019-2030
6.9.2 India Mycobacterium Tuberculosis Sales Value by Type (%), 2023 VS 2030
6.9.3 India Mycobacterium Tuberculosis Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Lupin
7.1.1 Lupin Profile
7.1.2 Lupin Main Business
7.1.3 Lupin Mycobacterium Tuberculosis Products, Services and Solutions
7.1.4 Lupin Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.1.5 Lupin Recent Developments
7.2 Macleods Pharmaceuticals
7.2.1 Macleods Pharmaceuticals Profile
7.2.2 Macleods Pharmaceuticals Main Business
7.2.3 Macleods Pharmaceuticals Mycobacterium Tuberculosis Products, Services and Solutions
7.2.4 Macleods Pharmaceuticals Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.2.5 Macleods Pharmaceuticals Recent Developments
7.3 Otsuka Pharmaceutical
7.3.1 Otsuka Pharmaceutical Profile
7.3.2 Otsuka Pharmaceutical Main Business
7.3.3 Otsuka Pharmaceutical Mycobacterium Tuberculosis Products, Services and Solutions
7.3.4 Otsuka Pharmaceutical Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.3.5 Johnson & Johnson Recent Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Profile
7.4.2 Johnson & Johnson Main Business
7.4.3 Johnson & Johnson Mycobacterium Tuberculosis Products, Services and Solutions
7.4.4 Johnson & Johnson Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.4.5 Johnson & Johnson Recent Developments
7.5 Pfizer
7.5.1 Pfizer Profile
7.5.2 Pfizer Main Business
7.5.3 Pfizer Mycobacterium Tuberculosis Products, Services and Solutions
7.5.4 Pfizer Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.5.5 Pfizer Recent Developments
7.6 Novartis
7.6.1 Novartis Profile
7.6.2 Novartis Main Business
7.6.3 Novartis Mycobacterium Tuberculosis Products, Services and Solutions
7.6.4 Novartis Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.6.5 Novartis Recent Developments
7.7 Abbott
7.7.1 Abbott Profile
7.7.2 Abbott Main Business
7.7.3 Abbott Mycobacterium Tuberculosis Products, Services and Solutions
7.7.4 Abbott Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.7.5 Abbott Recent Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Profile
7.8.2 AstraZeneca Main Business
7.8.3 AstraZeneca Mycobacterium Tuberculosis Products, Services and Solutions
7.8.4 AstraZeneca Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.8.5 AstraZeneca Recent Developments
7.9 Bayer
7.9.1 Bayer Profile
7.9.2 Bayer Main Business
7.9.3 Bayer Mycobacterium Tuberculosis Products, Services and Solutions
7.9.4 Bayer Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.9.5 Bayer Recent Developments
7.10 Merck
7.10.1 Merck Profile
7.10.2 Merck Main Business
7.10.3 Merck Mycobacterium Tuberculosis Products, Services and Solutions
7.10.4 Merck Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.10.5 Merck Recent Developments
7.11 Sanofi
7.11.1 Sanofi Profile
7.11.2 Sanofi Main Business
7.11.3 Sanofi Mycobacterium Tuberculosis Products, Services and Solutions
7.11.4 Sanofi Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.11.5 Sanofi Recent Developments
7.12 Thermo Fisher Scientific
7.12.1 Thermo Fisher Scientific Profile
7.12.2 Thermo Fisher Scientific Main Business
7.12.3 Thermo Fisher Scientific Mycobacterium Tuberculosis Products, Services and Solutions
7.12.4 Thermo Fisher Scientific Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.12.5 Thermo Fisher Scientific Recent Developments
7.13 Danaher
7.13.1 Danaher Profile
7.13.2 Danaher Main Business
7.13.3 Danaher Mycobacterium Tuberculosis Products, Services and Solutions
7.13.4 Danaher Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.13.5 Danaher Recent Developments
7.14 Roche
7.14.1 Roche Profile
7.14.2 Roche Main Business
7.14.3 Roche Mycobacterium Tuberculosis Products, Services and Solutions
7.14.4 Roche Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.14.5 Roche Recent Developments
7.15 Novartis
7.15.1 Novartis Profile
7.15.2 Novartis Main Business
7.15.3 Novartis Mycobacterium Tuberculosis Products, Services and Solutions
7.15.4 Novartis Mycobacterium Tuberculosis Revenue (US$ Million) & (2019-2024)
7.15.5 Novartis Recent Developments
8 Industry Chain Analysis
8.1 Mycobacterium Tuberculosis Industrial Chain
8.2 Mycobacterium Tuberculosis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Mycobacterium Tuberculosis Sales Model
8.5.2 Sales Channel
8.5.3 Mycobacterium Tuberculosis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Mycobacterium Tuberculosis Market Trends
    Table 2. Mycobacterium Tuberculosis Market Drivers & Opportunity
    Table 3. Mycobacterium Tuberculosis Market Challenges
    Table 4. Mycobacterium Tuberculosis Market Restraints
    Table 5. Global Mycobacterium Tuberculosis Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Mycobacterium Tuberculosis Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Mycobacterium Tuberculosis Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Mycobacterium Tuberculosis Product Type
    Table 9. Key Companies Time to Begin Mass Production of Mycobacterium Tuberculosis
    Table 10. Global Mycobacterium Tuberculosis Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycobacterium Tuberculosis as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Mycobacterium Tuberculosis Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Mycobacterium Tuberculosis Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Mycobacterium Tuberculosis Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Mycobacterium Tuberculosis Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Mycobacterium Tuberculosis Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Mycobacterium Tuberculosis Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Mycobacterium Tuberculosis Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Mycobacterium Tuberculosis Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Mycobacterium Tuberculosis Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Mycobacterium Tuberculosis Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Mycobacterium Tuberculosis Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Mycobacterium Tuberculosis Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Mycobacterium Tuberculosis Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Mycobacterium Tuberculosis Sales Value by Region (2019-2024) & (%)
    Table 27. Global Mycobacterium Tuberculosis Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Mycobacterium Tuberculosis Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Mycobacterium Tuberculosis Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Mycobacterium Tuberculosis Sales Value, (2025-2030) & (US$ Million)
    Table 31. Lupin Basic Information List
    Table 32. Lupin Description and Business Overview
    Table 33. Lupin Mycobacterium Tuberculosis Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of Lupin (2019-2024)
    Table 35. Lupin Recent Developments
    Table 36. Macleods Pharmaceuticals Basic Information List
    Table 37. Macleods Pharmaceuticals Description and Business Overview
    Table 38. Macleods Pharmaceuticals Mycobacterium Tuberculosis Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of Macleods Pharmaceuticals (2019-2024)
    Table 40. Macleods Pharmaceuticals Recent Developments
    Table 41. Otsuka Pharmaceutical Basic Information List
    Table 42. Otsuka Pharmaceutical Description and Business Overview
    Table 43. Otsuka Pharmaceutical Mycobacterium Tuberculosis Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of Otsuka Pharmaceutical (2019-2024)
    Table 45. Otsuka Pharmaceutical Recent Developments
    Table 46. Johnson & Johnson Basic Information List
    Table 47. Johnson & Johnson Description and Business Overview
    Table 48. Johnson & Johnson Mycobacterium Tuberculosis Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of Johnson & Johnson (2019-2024)
    Table 50. Johnson & Johnson Recent Developments
    Table 51. Pfizer Basic Information List
    Table 52. Pfizer Description and Business Overview
    Table 53. Pfizer Mycobacterium Tuberculosis Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of Pfizer (2019-2024)
    Table 55. Pfizer Recent Developments
    Table 56. Novartis Basic Information List
    Table 57. Novartis Description and Business Overview
    Table 58. Novartis Mycobacterium Tuberculosis Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of Novartis (2019-2024)
    Table 60. Novartis Recent Developments
    Table 61. Abbott Basic Information List
    Table 62. Abbott Description and Business Overview
    Table 63. Abbott Mycobacterium Tuberculosis Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of Abbott (2019-2024)
    Table 65. Abbott Recent Developments
    Table 66. AstraZeneca Basic Information List
    Table 67. AstraZeneca Description and Business Overview
    Table 68. AstraZeneca Mycobacterium Tuberculosis Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of AstraZeneca (2019-2024)
    Table 70. AstraZeneca Recent Developments
    Table 71. Bayer Basic Information List
    Table 72. Bayer Description and Business Overview
    Table 73. Bayer Mycobacterium Tuberculosis Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of Bayer (2019-2024)
    Table 75. Bayer Recent Developments
    Table 76. Merck Basic Information List
    Table 77. Merck Description and Business Overview
    Table 78. Merck Mycobacterium Tuberculosis Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of Merck (2019-2024)
    Table 80. Merck Recent Developments
    Table 81. Sanofi Basic Information List
    Table 82. Sanofi Description and Business Overview
    Table 83. Sanofi Mycobacterium Tuberculosis Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of Sanofi (2019-2024)
    Table 85. Sanofi Recent Developments
    Table 86. Thermo Fisher Scientific Basic Information List
    Table 87. Thermo Fisher Scientific Description and Business Overview
    Table 88. Thermo Fisher Scientific Mycobacterium Tuberculosis Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of Thermo Fisher Scientific (2019-2024)
    Table 90. Thermo Fisher Scientific Recent Developments
    Table 91. Danaher Basic Information List
    Table 92. Danaher Description and Business Overview
    Table 93. Danaher Mycobacterium Tuberculosis Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of Danaher (2019-2024)
    Table 95. Danaher Recent Developments
    Table 96. Roche Basic Information List
    Table 97. Roche Description and Business Overview
    Table 98. Roche Mycobacterium Tuberculosis Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of Roche (2019-2024)
    Table 100. Roche Recent Developments
    Table 101. Novartis Basic Information List
    Table 102. Novartis Description and Business Overview
    Table 103. Novartis Mycobacterium Tuberculosis Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Mycobacterium Tuberculosis Business of Novartis (2019-2024)
    Table 105. Novartis Recent Developments
    Table 106. Key Raw Materials Lists
    Table 107. Raw Materials Key Suppliers Lists
    Table 108. Mycobacterium Tuberculosis Downstream Customers
    Table 109. Mycobacterium Tuberculosis Distributors List
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
    Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Mycobacterium Tuberculosis Product Picture
    Figure 2. Global Mycobacterium Tuberculosis Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Mycobacterium Tuberculosis Sales Value (2019-2030) & (US$ Million)
    Figure 4. Mycobacterium Tuberculosis Report Years Considered
    Figure 5. Global Mycobacterium Tuberculosis Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Mycobacterium Tuberculosis Revenue in 2023
    Figure 7. Mycobacterium Tuberculosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Real-time Inspection Picture
    Figure 9. Nucleic Acid Amplification Test Picture
    Figure 10. Skin Test for Tuberculosis Picture
    Figure 11. Other Picture
    Figure 12. Global Mycobacterium Tuberculosis Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Mycobacterium Tuberculosis Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospital
    Figure 15. Product Picture of Specialist Clinic
    Figure 16. Product Picture of Diagnostic Laboratory
    Figure 17. Global Mycobacterium Tuberculosis Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Mycobacterium Tuberculosis Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Mycobacterium Tuberculosis Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Mycobacterium Tuberculosis Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Mycobacterium Tuberculosis Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Mycobacterium Tuberculosis Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Mycobacterium Tuberculosis Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Mycobacterium Tuberculosis Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Mycobacterium Tuberculosis Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Mycobacterium Tuberculosis Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Mycobacterium Tuberculosis Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Mycobacterium Tuberculosis Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Mycobacterium Tuberculosis Sales Value (%), (2019-2030)
    Figure 30. United States Mycobacterium Tuberculosis Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Mycobacterium Tuberculosis Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Mycobacterium Tuberculosis Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Mycobacterium Tuberculosis Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Mycobacterium Tuberculosis Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Mycobacterium Tuberculosis Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Mycobacterium Tuberculosis Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Mycobacterium Tuberculosis Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Mycobacterium Tuberculosis Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Mycobacterium Tuberculosis Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Mycobacterium Tuberculosis Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Mycobacterium Tuberculosis Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Mycobacterium Tuberculosis Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Mycobacterium Tuberculosis Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Mycobacterium Tuberculosis Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Mycobacterium Tuberculosis Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Mycobacterium Tuberculosis Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Mycobacterium Tuberculosis Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Mycobacterium Tuberculosis Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Mycobacterium Tuberculosis Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Mycobacterium Tuberculosis Sales Value by Application (%), 2023 VS 2030
    Figure 51. Mycobacterium Tuberculosis Industrial Chain
    Figure 52. Mycobacterium Tuberculosis Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart